Currently, there are no medications that have been approved specifically for prevention or treatment of<unk> . The use of medications for treatment of Alzheimer's dementia, such as cholinesterase inhibitors and memantine, has shown small improvement of cognition in<unk> . This is most likely due to the drugs' actions on co-existing AD-related pathology. Multiple studies found a small benefit in<unk>  treatment with: memantine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist; cholinesterase inhibitors galantamine, donepezil, rivastigmine; Studies have shown that an extract of Ginkgo biloba EGb761 improves cognition, daily activities, and quality of life in treating<unk> , and is seen to be effective regardless of the severity of symptoms. In those with celiac disease or non-celiac gluten sensitivity, a strict gluten-free diet may relieve symptoms of mild cognitive impairment. It should be started as soon as possible. There is no evidence that a gluten free diet is useful against advanced dementia. People with no digestive symptoms are less likely to receive early diagnosis and treatment. General management of dementia includes referral to community services, aid with judgment and decision-making regarding legal and ethical issues (e.g., driving, capacity, advance directives), and consideration of caregiver stress. Behavioral and affective symptoms deserve special consideration in this patient group. These problems tend to resist conventional psychopharmacological treatment, and often lead to hospital admission and placement in permanent care.
Vascular dementia
Dementia with Lewy bodies  Dementia with Lewy bodies  1
Alcohol-related dementia
Subcortical dementia
Depression of Alzheimer disease
Early-onset Alzheimer's disease
Semantic dementia
Alzheimer's disease